|
Manufacturer received report of blisters on patient breast after use of device.According to the patient report, the blisters occured underneath clothing while undergoing skin exposure to red light on an adjacent area.Manufacturer first received notification of patient report from fda medwatch notification on march 24, 2023.Manufacturer has spoken to the healthcare proivder and learned that they had not seen the alleged blisters, and that the patient had continued treatments for a period of time after the alleged incident date.Manufacturer has unsuccessfully reached out to patient.Healthcare provider is in process of returning device for inspection by manufacturer, although the device continues operating normally according to the provider.
|